If ER and PR statuses are unknown, then the site(s) of recurrence, disease-free interval, response to previous treatment, and menopausal status are useful in the selection of chemotherapy or hormone therapy.[7] Patients with locoregional recurrence should be considered for further local treatment (e.g., mastectomy).
In one series, the 5-year actuarial rate of relapse for patients treated for invasive recurrence after initial breast conservation and radiation therapy was 52%.[4] Treatment options also depend on the site of recurrence, as follows: Chest wall: Local chest wall recurrence after mastectomy is often a sign of widespread disease, but, in a subset of patients, it may be the only site of recurrence.